RNA targeting small molecules therapeutics market to reach $4.84 billion by 2030 at 11.7% CAGR, driven by increasing cancer cases and rising incidence of genetic disorders worldwide.
Read MoreSarcoidosis drug market to reach $10.98 billion by 2030 at 6.9% CAGR, driven by increasing number of clinical trials and demand for innovative treatments.
Read MoreSalbutamol oral liquid market to reach $1.52 billion by 2030 at 5.3% CAGR, driven by increasing incidences of respiratory disorders, rising healthcare expenditures, and air pollution.
Read MoreSalbutamol active pharmaceutical ingredient market to reach $4.14 billion by 2030 at 6.3% CAGR, driven by increasing incidence of respiratory diseases.
Read MoreRoxadustat market to reach $9.56 billion by 2030 at 6.9% CAGR, driven by rising number of people with chronic kidney disease globally.
Read MoreRotavirus vaccine market to reach $16.45 billion by 2030 at 10.1% CAGR, driven by rising birth rates and increasing focus on pediatric immunization programs.
Read MoreRotator cuff injuries market to reach $3.66 billion by 2030 at 7.1% CAGR, driven by increasing incidence of sports- and physical activity-related injuries.
Read MoreRosai-dorfman disease market to reach $0.76 billion by 2030 at 7.2% CAGR, driven by growing demand for targeted therapies and rising immune-related complications.
Read MoreRNA targeting small molecules therapeutics market to reach $4.84 billion by 2030 at 11.7% CAGR, driven by increasing cancer cases and rising incidence of genetic disorders worldwide.
Read More
What level of CAGR-driven expansion is anticipated in the Radiopharmaceuticals Market between 2026 and 2030?
Read More